Intrarosa

Discussion in 'AMAG Pharmaceuticals' started by anonymous, Feb 17, 2017 at 10:27 AM.

Tags: Edit
  1. anonymous

    anonymous Guest

    It is a huge market with long time establishes products. We are ramping up new starts every month. We are killing Osphena-t hey dropped new and refills every quarter over quarter last year and are down significantly 2017 vs 2016 According to a friend that works there due for a 30-40% sales force reduction in Q1. Stay the course -we are winning.
     

  2. anonymous

    anonymous Guest

    I hope so. Not a lot of posivity lately
     
  3. anonymous

    anonymous Guest

    Then why are they higher ups planning to lay off so many of us that have been working our tails off?
     
  4. anonymous

    anonymous Guest

    Trust me when I tell you this is true. I heard it from my manager. Leadership continues to founder and are overwhelmed with the mess they have made. We are a group of seasoned and capable reps but are trying to operate in a culture of fear. It's such a shame, Intrarosa is a great product. Too bad it didn't go to a company that knew how to run a sampling sales force. Oh, and to top it off, I learned from one of my doctors that BMT is having a lot of trouble keeping women in the trial due to nausea and vomiting. My plan was to try to wait it out for BMT, which was sold to us my management as a game-changing drug. Plans change.
     
  5. anonymous

    anonymous Guest

    How many people will be let go? I did not hear of them reducing headcount? When?
     
  6. anonymous

    anonymous Guest

    Can someone who is in the know tell us what is going on?
     
  7. anonymous

    anonymous Guest

    The bottom 1/3 of sales will be going on PIP's.
     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

    22,000 scripts year end..Projected 85,000
    scripts. It's not the Salesforce that's the problem, it's the drug. Managers and reps are leaving there's a reason for that. Just give severance packages and be done with it. Once everyone gets wind of how many scripts are needed for 2018... a majority of reps will be on pips.
     
  10. anonymous

    anonymous Guest

    How does putting good reps who have been working their tails off onto pips help things? It is still early. It takes a long time to get launches off and running; especially with a small company.
     
  11. anonymous

    anonymous Guest

    Reps have already started leaving in droves. It's a good product, the company just really mismanaged the launch. The Co-pay cards should have been great but so many scripts were lost because of a problem with them, the sample debacle (need I say more), the call entry platform, the culture of fear with upper management and HR, the constant changing of the language, the handling of the studies, it's terrifically terrible. Now the new law in CA prohibiting the use of co-pay cards plus the launch of two generics of Estrace. I'm interviewing (along with half my team). It's been a phenomenal disappointment.
     
  12. anonymous

    anonymous Guest

    don't fall for this one guy who keeps on writing bad stuff here.
    I heard he didn't get the job....
     
  13. anonymous

    anonymous Guest

    Sorry but you people were told when you were interviewing that this product was never going to get off the ground. I assume anyone with any women's health experience knew this going in and took the job for the fat salary. You guys will be laid off, believe it.
     
  14. anonymous

    anonymous Guest

    And cue the mass exodus...
     
  15. anonymous

    anonymous Guest

    What Reps have left?
     
  16. anonymous

    anonymous Guest

    Quite a few gave notice last week with more to come, apparently.
     
  17. anonymous

    anonymous Guest

    If you know so much, what territories ?
     
  18. anonymous

    anonymous Guest

    its that same guy
     
  19. anonymous

    anonymous Guest

    just heard like 8 people quit. Mostly in the west.
     
  20. anonymous

    anonymous Guest

    All Going to Cooper for PARAGARD